We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma (DESPARTH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02304289
Recruitment Status : Terminated (slow recruitment of patients)
First Posted : December 1, 2014
Last Update Posted : October 27, 2021
Sponsor:
Collaborators:
University Ghent
Anticancer Fund, Belgium
Information provided by (Responsible Party):
University Hospital, Ghent

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016